314 related articles for article (PubMed ID: 7638777)
1. [Vasculopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome].
Alekberova ZS; Reshetniak TM; Rodenska-Lopovok SG; Aleksandrova EN; Kalashnikova LA; Nasonov EL; Mach ES; Nasonova VA
Ter Arkh; 1995; 67(5):41-4. PubMed ID: 7638777
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
4. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
6. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
7. [Antiphospholipid syndrome and exogenic risk factors in thromboses].
Tikhonova TL; Mach ES; Shirokova IE; Reshetniak TM
Ter Arkh; 2004; 76(11):71-4. PubMed ID: 15658543
[TBL] [Abstract][Full Text] [Related]
8. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
[TBL] [Abstract][Full Text] [Related]
9. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
10. [The role of hyperhomocysteinemia in systemic lupus erythematosus and antiphospholipid syndrome].
Reshetniak TM; Shirokova IE; Lisitskaia TL
Ter Arkh; 2006; 78(6):24-30. PubMed ID: 16881359
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
12. [Anti-phospholipid syndrome nephropathy].
Nochy D; Daugas E; Hill G; Piette JC
Ann Med Interne (Paris); 2003 Feb; 154(1):51-8. PubMed ID: 12746659
[TBL] [Abstract][Full Text] [Related]
13. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS.
Tektonidou MG; Sotsiou F; Moutsopoulos HM
J Rheumatol; 2008 Oct; 35(10):1983-8. PubMed ID: 18688914
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Miroshnichenko NG; Samokishina NA; Serova AG; Nesterova SG
Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045
[TBL] [Abstract][Full Text] [Related]
17. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
[TBL] [Abstract][Full Text] [Related]
18. [Antiphospholipid syndrome--the description of two cases].
Podrazilová L; Peterová V; Olejárová M; Seidl Z; Dostál C
Vnitr Lek; 2006 Jan; 52(1):89-94. PubMed ID: 16526206
[TBL] [Abstract][Full Text] [Related]
19. [Arterial hypertension and the antiphospholipid syndrome].
Nasonov EL; Karpov IuA; Alekberova ZS; Vil'chinskaia MIu; Fomicheva OA; Aleksandrova EN; Reshetniak TM; Kliukvina NG; Andreev AIa
Ter Arkh; 1996; 68(2):37-40. PubMed ID: 8771655
[TBL] [Abstract][Full Text] [Related]
20. Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome.
Sipek-Dolnicar A; Hojnik M; Rozman B; Vizjak A; Ferluga D
Wien Klin Wochenschr; 2000 Aug; 112(15-16):707-10. PubMed ID: 11020961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
